FinTechFunding

Proteomics International: Raises $6M for high-tech blood test

  • Proteomics International (PIQ) has received firm commitments to undertake a $6 million share placement
  • 12.5 million shares will issued to sophisticated and professional investors at 48 cents each
  • Additionally, the company will issue 2.2 million options to Euroz Hartleys Securities and Candour Advisory
  • These options will have an exercise price of 75 cents with expiry two years after issue
  • Proteomics will also use the funds to manufacture, market, and speed-up regulatory approvals for its PromarkerD test and strengthen its balance sheet
  • Proteomics is up 9 per cent on the market with shares trading for 60 cents each
Previous article
MRG Metals: Completes phase two drilling in Mozambique
Next article
PainChek: Signs partnership deal with disability service provider
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

NextGen Nordics 2026 Strengthens Future of Money with 29 Leading Voices

A lineup of key speakers will shape discussions on financial innovation.Highlights: NextGen Nordics 2026 to feature 29 key...
FinTech

Revolut Aims to Go Public Within Two Years

The fintech prepares for a potentially significant market entry.Highlights: Revolut plans to pursue an IPO within the next...
FinTech

Mexican Neobank Plata Achieves $5 Billion Valuation

Plata rises as a leader in the Mexican fintech landscape.Highlights: Plata's valuation hits $5 billion following a successful...
FinTech

Piraeus Bank Strengthens AI Capabilities with Accenture and Anthropic Hub

New AI hub aims to enhance banking services and improve customer experiences.Highlights: Piraeus Bank launches an AI hub...